Moonshot AI is considering raising up to $5bn in a Hong Kong initial public offering, potentially before the end of 2026, Bloomberg reported on 4 September 2026. The account, sourced to people familiar with the matter who asked not to be identified because the information is private, says the Beijing laboratory has filed confidentially and has added Bank of America as overall coordinator alongside sponsor banks China International Capital Corporation, Deutsche Bank and Goldman Sachs. Moonshot has announced nothing on the record, and neither the syndicate nor the size has been independently verified.
The target itself has moved. Reports on 3 September 2026 put the figure nearer $3bn, so the $5bn number is best treated as the most advanced version of a figure still being briefed, not as settled.
A listing route that is already open
Moonshot would not be the first Chinese AI laboratory to reach the public markets. Zhipu AI and MiniMax debuted on the Hong Kong Stock Exchange on 8 and 9 January 2026, seeking $560m and up to $539m respectively. Both offerings were oversubscribed, and both companies went public before OpenAI or Anthropic had filed to do so. A raise of the size Bloomberg describes would be several times what Zhipu and MiniMax took between them.
What export controls cover, and what they do not
US export controls restrict what American companies may sell, principally advanced chips and the equipment used to make them. They do not govern what American banks may underwrite in Hong Kong. The reported presence of Bank of America, Goldman Sachs and Deutsche Bank on a Beijing AI laboratory's listing illustrates where the regulatory perimeter stops: the fee pool on a $5bn offering is substantial, and none of it engages the hardware rules.
The hardware rules themselves have not constrained Moonshot in the way the policy assumed, according to the TNW account. Moonshot trained its flagship Kimi K3 model on a 20,000-chip cluster accessed through Alibaba's cloud infrastructure, with multiple accounts identifying the hardware as Nvidia H200 accelerators. Moonshot billed K3 as the world's largest open-weight model, at 2.8 trillion parameters, when it launched in July 2026. The reporting also notes the contrast with the Gulf: Abu Dhabi's G42 is reportedly weighing a sale of majority ownership to American companies to preserve chip access, while Moonshot is turning to public equity instead.
The economics behind the valuation
Valuation figures attached to Moonshot have risen during 2026. Earlier coverage described a planned listing within six months at a $30bn valuation, and a subsequent raise chasing $50bn. Annual recurring revenue has been reported at around $300m, and the company at one point paused subscriptions because it ran short of GPUs.
The listed comparables cut both ways. On prospectus figures cited by Rest of World, Zhipu lost roughly $330m on $27m of revenue in the first half of 2025, and MiniMax lost $512m on $53m over a nine-month period. Investor appetite for Chinese AI listings is demonstrated; durable profitability is not. Moonshot's aggressive token pricing, and the global technology and semiconductor selloff that followed the K3 release, have also fed into how American AI valuations are argued.
What is established and what is merely claimed
Established: Zhipu and MiniMax listed in Hong Kong on 8 and 9 January 2026, and both offerings were oversubscribed. US export controls regulate chip sales and do not regulate underwriting. Washington blacklisted Zhipu in January 2025, restricting its access to US technology. Moonshot released Kimi K3 in July 2026 with open weights.
Claimed but not proven: That Moonshot has filed confidentially, that it is targeting up to $5bn, and that Bank of America, CICC, Deutsche Bank and Goldman Sachs form the syndicate all rest on anonymous sourcing reported by Bloomberg and relayed by TNW, with no on-the-record confirmation from Moonshot or the banks. The identification of the K3 training hardware as H200 accelerators comes from multiple accounts but is unconfirmed. The reported $300m revenue figure, the $30bn and $50bn valuations and the GPU-related subscription pause are likewise unverified. A confidential filing is not a prospectus, and the size, timing, valuation and syndicate of any listing can all change before anything prices.